Advantage Portfolio RPRX Holdings History
Advantage Portfolio's Royalty Pharma PLC Holding Summary
As of 2025-03-31, MORGAN STANLEY INSTITUTIONAL FUND INC held 295,859.00 shares of Royalty Pharma PLC(RPRX), totaling $9.21 Mil. This investment constitutes 5.1% of their stock portfolio, and MORGAN STANLEY INSTITUTIONAL FUND INC now holds 0.07% of the outstanding Royalty Pharma PLC(RPRX) stock.
The initial trade took place in 2020Q2. And since then Advantage Portfolio has made 8 purchases of RPRX, at an average price of $43.85, for a total of 690,538.00 shares. In addition, there have been 10 sales at an average price of $37.72 for 394,679.00 shares. Based on historical transaction data and RPRX's current price of $35.44, Advantage Portfolio's estimated gain on his RPRX holdings is $-4.90 Mil, reflecting a -16.19% gain to date.
Advantage Portfolio RPRX ($35.44) Holding Chart
Advantage Portfolio RPRX ($35.44) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
